Literature DB >> 27595279

Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system.

P Anandi1, X Tian2, F Chinian1, C R Cantilena1, N Dunavin1, N Hensel1, D Draper1, E Koklanaris1, S Maxwell1, J Superata1, P Muranski1, M Battiwalla1, S Paczesny3, A J Barrett1, S Ito1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27595279      PMCID： PMC8734000          DOI： 10.1038/bmt.2016.226

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

Authors:  Sophie Paczesny; Frances T Hakim; Joseph Pidala; Kenneth R Cooke; Julia Lathrop; Linda M Griffith; John Hansen; Madan Jagasia; David Miklos; Steven Pavletic; Robertson Parkman; Estelle Russek-Cohen; Mary E D Flowers; Stephanie Lee; Paul Martin; Georgia Vogelsang; Marc Walton; Kirk R Schultz
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-30       Impact factor: 5.742

Review 2.  Discovery and validation of graft-versus-host disease biomarkers.

Authors:  Sophie Paczesny
Journal:  Blood       Date:  2012-11-19       Impact factor: 22.113

3.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

4.  A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study.

Authors:  John E Levine; Thomas M Braun; Andrew C Harris; Ernst Holler; Austin Taylor; Holly Miller; John Magenau; Daniel J Weisdorf; Vincent T Ho; Javier Bolaños-Meade; Amin M Alousi; James L M Ferrara
Journal:  Lancet Haematol       Date:  2014-12-23       Impact factor: 18.959

5.  High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.

Authors:  Doris M Ponce; Patrick Hilden; Christen Mumaw; Sean M Devlin; Marissa Lubin; Sergio Giralt; Jenna D Goldberg; Alan Hanash; Katharine Hsu; Robert Jenq; Miguel-Angel Perales; Craig Sauter; Marcel R M van den Brink; James W Young; Renier Brentjens; Nancy A Kernan; Susan E Prockop; Richard J O'Reilly; Andromachi Scaradavou; Sophie Paczesny; Juliet N Barker
Journal:  Blood       Date:  2014-11-06       Impact factor: 22.113

6.  Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.

Authors:  James L M Ferrara; Andrew C Harris; Joel K Greenson; Thomas M Braun; Ernst Holler; Takanori Teshima; John E Levine; Sung W J Choi; Elisabeth Huber; Karin Landfried; Koichi Akashi; Mark Vander Lugt; Pavan Reddy; Alice Chin; Qing Zhang; Samir Hanash; Sophie Paczesny
Journal:  Blood       Date:  2011-10-06       Impact factor: 22.113

7.  Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation.

Authors:  R Q Le; X Tian; N A Jain; K Lu; S Ito; D A Draper; P Anandi; C S Hourigan; N Dunavin; A John Barrett; M Battiwalla
Journal:  Bone Marrow Transplant       Date:  2015-05-18       Impact factor: 5.483

8.  Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.

Authors:  Sung W Choi; Carrie L Kitko; Thomas Braun; Sophie Paczesny; Gregory Yanik; Shin Mineishi; Oleg Krijanovski; Dawn Jones; Joel Whitfield; Kenneth Cooke; Raymond J Hutchinson; James L M Ferrara; John E Levine
Journal:  Blood       Date:  2008-05-23       Impact factor: 22.113

9.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

Authors:  Mark T Vander Lugt; Thomas M Braun; Samir Hanash; Jerome Ritz; Vincent T Ho; Joseph H Antin; Qing Zhang; Chee-Hong Wong; Hong Wang; Alice Chin; Aurélie Gomez; Andrew C Harris; John E Levine; Sung W Choi; Daniel Couriel; Pavan Reddy; James L M Ferrara; Sophie Paczesny
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245
  9 in total
  1 in total

1.  High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring.

Authors:  A T Nunes; P Jain; D E Kleiner; N N Shah; P Anandi; F Chinian; P Muranski; M Battiwalla; A J Barrett; S Ito
Journal:  Bone Marrow Transplant       Date:  2017-03-13       Impact factor: 5.483
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.